Twin Tree Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-286,700
| Closed | -$30.8M | – | 1484 |
|
|
2025
Q2 | $30.8M | Buy |
+286,700
| New | +$29M | 0.06% | 328 |
|
|
2024
Q1 | – | Sell |
-30,500
| Closed | -$1.76M | – | 1292 |
|
|
2023
Q4 | $1.76M | Buy |
+30,500
| New | +$1.63M | ﹤0.01% | 1077 |
|
|
2022
Q3 | – | Sell |
-186,800
| Closed | -$6.96M | – | 1335 |
|
|
2022
Q2 | $6.96M | Sell |
186,800
-208,000
| -53% | -$8.47M | 0.01% | 755 |
|
|
2022
Q1 | $17.5M | Buy |
394,800
+43,800
| +12% | +$1.9M | 0.03% | 521 |
|
|
2021
Q4 | $14.9M | Buy |
+351,000
| New | +$14.7M | 0.03% | 500 |
|
|
2021
Q2 | – | Sell |
-100,600
| Closed | -$3.89M | – | 1347 |
|
|
2021
Q1 | $3.89M | Sell |
100,600
-353,800
| -78% | -$13.4M | 0.01% | 701 |
|
|
2020
Q4 | $16.3M | Sell |
454,400
-790,200
| -63% | -$28.5M | 0.07% | 330 |
|
|
2020
Q3 | $47.6M | Buy |
1,244,600
+482,500
| +63% | +$18.6M | 0.2% | 114 |
|
|
2020
Q2 | $26.8M | Buy |
762,100
+534,000
| +234% | +$19.2M | 0.11% | 215 |
|
|
2020
Q1 | $7.44M | Buy |
228,100
+182,700
| +402% | +$7.14M | 0.04% | 392 |
|
|
2019
Q4 | $2.05M | Buy |
+45,400
| New | +$1.9M | 0.01% | 718 |
|
|
2019
Q2 | – | Sell |
-8,400
| Closed | -$322K | – | 1250 |
|
|
2019
Q1 | $322K | Sell |
8,400
-71,100
| -89% | -$2.72M | ﹤0.01% | 998 |
|
|
2018
Q4 | $2.81M | Buy |
+79,500
| New | +$2.88M | 0.02% | 641 |
|
|
2018
Q3 | – | Sell |
-335,500
| Closed | -$11M | – | 1057 |
|
|
2018
Q2 | $11M | Sell |
335,500
-470,300
| -58% | -$14.2M | 0.07% | 254 |
|
|
2018
Q1 | $22M | Buy |
+805,800
| New | +$21.9M | 0.18% | 88 |
|
|
2016
Q4 | – | Sell |
-99,000
| Closed | -$2.36M | – | 1169 |
|
|
2016
Q3 | $2.36M | Buy |
99,000
+60,000
| +154% | +$1.43M | 0.03% | 468 |
|
|
2016
Q2 | $911K | Sell |
39,000
-8,200
| -17% | -$177K | 0.01% | 687 |
|
|
2016
Q1 | $888K | Buy |
+47,200
| New | +$829K | 0.02% | 647 |
|
|
2015
Q4 | – | Sell |
-54,200
| Closed | -$889K | – | 1390 |
|
|
2015
Q3 | $889K | Sell |
54,200
-46,000
| -46% | -$786K | 0.02% | 582 |
|
|
2015
Q2 | $1.77M | Buy |
100,200
+36,400
| +57% | +$650K | 0.04% | 438 |
|
|
2015
Q1 | $1.13M | Buy |
+63,800
| New | +$1.01M | 0.03% | 557 |
|
|
2014
Q1 | – | Sell |
-107,700
| Closed | -$1.29M | – | 936 |
|
|
2013
Q4 | $1.29M | Buy |
+107,700
| New | +$1.27M | 0.03% | 535 |
|
Other funds holding BSX
VCM
VPM
Twin Tree Management's BSX Position: Q2 2025 in Review
Twin Tree Management sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 15,923 shares — an estimated $1.61M sold.
Twin Tree Management first reported a position in BSX in Q3 2013 and held it in 33 quarters. The position peaked at $18.1M in Q2 2023. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.
- Twin Tree Management reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
- Twin Tree Management sold 15,923 Boston Scientific shares in Q2 2025, an estimated $1.61M.
- Twin Tree Management first reported a position in Boston Scientific in Q3 2013 and held it in 33 quarters.
- Twin Tree Management's Boston Scientific position peaked at $18.1M in Q2 2023.
- 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.
Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.